GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Vendor] WXT order #9 — the Netherlands, 33 days, no drama, receipts inside — 57 comments in the full submission. View in context.
4.4k
c/insurancefights·submitted 2 years ago by u/dose_diary_dana

[Vendor] WXT order #9 — the Netherlands, 33 days, no drama, receipts inside

Templatebranch of 10 comments

Been lurking in c/cryptopay for about 12 months and finally have something worth posting. Short version: week 39, 2.4mg, and appeal is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 23 threads, and the answers split roughly down the middle. What I actually want to know is…

Read the full submission and all 57 comments →

This branch

10 comments, started 2 years ago
u/wholesome_lurker115 points·2 years ago

Half-life is about 168 hours, so steady state lands around week 2–5. Practical consequence: what you feel in week 1 is not what that dose does.

replysharereportpermalink
u/hugo_pires38 points·2 years ago

External review overturned the denial. Took 4 weeks but the process exists.

replysharereportpermalink
u/saskia_rahimi11 points·2 years ago

Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.

replysharereportpermalink
u/kian_balogun27 points·2 years ago

appeal letter templates are in the wiki

replysharereportpermalink
u/maren_sorensen0 points·2 years ago

appeal letter templates are in the wiki

Adding to this: prior authorization is doing more work than the comment implies.

replysharereportpermalink
u/peak_area_peteanalytical71 points·2 years ago

Disagree. What you are describing is consistent with external review, not with what you concluded.

replysharereportpermalink
u/adaeze_weiss35 points·2 years ago

say which country and which plan type

replysharereportpermalink
u/milan_wikstrom12 points·2 years ago

external review is the appeal after insurance says no

replysharereportpermalink
u/kian_ferreira23 points·2 years ago·edited

Disagree.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

replysharereportpermalink
u/step_therapy_s13 points·2 years ago

formulary exclusions are negotiable sometimes

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.